Key Market Trends & Highlights The GLP-1 drug market is experiencing robust growth driven by increasing demand for innovative therapies and digital health integration
They are prescription-only medicines and are used to treat type-2 diabetes and, in some cases, weight management under medical supervision
Signs Emotional Eating May Be Affecting Why GLP-1 medications are not working Some common signs include: Eating when you are not physically hungry Using food to manage stress or emotions Feeling out of control around certain foods Frequent evening or nighttime overeating Thinking about food despite feeling physically full Feeling guilty after eating Experiencing cycles of restriction followed by overeating If these patterns are present, emotional eating may be contributing to why a GLP-1 medication is not producing the results you expected
Effect of liraglutide on arterial inflammation assessed as [ 18 F]FDG uptake in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial
Dipeptidyl Peptidase-4 Inhibition and the Treatment of Type 2 Diabetes: Preclinical Biology and Mechanisms of Action
10.1016/j.ijcard.2018.12.005 51 SukumaranV.TsuchimochiH.SonobeT.WaddinghamM
